Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome
申请人:Epitracker, Inc.
公开号:US10792266B2
公开(公告)日:2020-10-06
Compositions comprising fatty acid analogs are provided for treating metabolic syndrome, anemia, cancer, cardiovascular disease, diabetes, dyslipidemia, hypertension, inflammation, insulin resistance, prediabetes, fatty liver disease, steatohepatitis, iron overload, neurodegenerative diseases, including Alzheimer's disease and other forms of dementia, and other related conditions. Methods for the diagnosis and monitoring of metabolic syndrome and other conditions are also provided.
提供了包含脂肪酸类似物的组合物,用于治疗代谢综合征、贫血、癌症、心血管疾病、糖尿病、血脂异常、高血压、炎症、胰岛素抵抗、糖尿病前期、脂肪肝、脂肪性肝炎、铁超载、神经退行性疾病(包括阿尔茨海默病和其他形式的痴呆症)以及其他相关疾病。还提供了诊断和监测代谢综合征和其他疾病的方法。